Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Albany International to Retain Salt Lake City Facility After Completing Strategic Review

Albany International to Retain Salt Lake City Facility After Completing Strategic Review

MT newswireMT newswire2026/09/01 21:26
05:26 PM EDT, 09/01/2026 (MT Newswires) -- Albany International (AIN) will retain its Amelia Earhart Drive facility in Salt Lake City, Utah, and continue operations under amended terms after completing a strategic review of the site, the company said late Tuesday. The company said it renegotiated Boeing (BA) 787 contract for one-piece composite fuselage frames and entered new contract terms with Lockheed Martin's (LMT) Sikorsky on the CH-53K helicopter program. For Q3, Albany raised its adjusted earnings outlook to $1.40 to $1.50 per share from a prior range of $0.60 to $0.70, and kept its consolidated net revenue outlook at $320 million to $330 million. Three analysts polled by FactSet expect $0.68 and $325.8 million, respectively. For Q4, Albany guided adjusted EPS of $0.65 to $0.75 on net revenue of $325 million to $335 million. Three analysts expect $0.72 and $328.7 million, respectively.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas